It is estimated that over 150 million people globally are struggling with erectile dysfunction. As people seek treatment for this disorder, a US-based subscription-based app Regimen has gained traction. The app has just secured $2.25 million (nearly £1.62 million) in a seed funding round led by Ringier Digital Ventures.
Eyes to initiate clinical trials
Regimen will use the funds to integrate its therapy with established healthcare models all over the world. Also, it will initiate clinical trials to further strengthen its scientific evidence base. Besides this, the app is available to the public at a subscription cost of $95 for a period of six months. The company hopes that it will be able to offer reimbursement via insurance providers in the future.
Regimen co-founder and managing director Max Kersting said: “Over the last year, we’ve been able to demonstrate the demand for, and effectiveness of, holistic therapy for erectile dysfunction, which is one of the most common intimate health issues worldwide. With this round of investment, we will be able to further personalize the program to each client’s needs through AI, strengthen our scientific leadership position and evidence base, co-create models with established healthcare organizations, and ultimately make Regimen more available to everyone who could benefit from it, all over the world.”
David Hug, the investment advisor of Ringier Digital Ventures, said: “The market for digital holistic men’s health is underserved. We believe especially topics that are very personal and sensitive like ED can be addressed extremely well with digital products. The Regimen team has proven with the KPI’s that their approach works and is appreciated by customers. We are very delighted to take the next steps with Max and his team.”
Part of DigitalHealth.London Accelerator program
Currently, Regimen is a part of DigitalHealth.London Accelerator program, which is connected to UK’s NHS. It is gaining attention from global healthcare organisations as a more sustainable way of treating patients with ED than drug therapy or in-person visits. The programme is a prestigious accelerator for digital health companies with a product or service that has high potential to meet the current challenges facing the NHS and social care today, as a result of the COVID-19 pandemic.
Jenny Thomas, Programme Director for the DigitalHealth.London Accelerator, also noted: “DigitalHealth.London’s Accelerator programme supports companies that offer novel solutions for the NHS’s biggest challenges. Erectile dysfunction is a key predictor for severe health issues that are part of the long-term strategy of the NHS, including cardiovascular and mental health. Tackling the underlying factors of erectile dysfunction can not only improve erections but also has the potential to prevent severe health events. We are proud to support Regimen as part of the Accelerator programme, as a company that is addressing the most intimate health issues of the male population with holistic, personalized health and self-care programs – starting with erectile dysfunction.”
First holistic digital ED therapy
Regimen was founded by Max Kersting along with his two co-founders Dr. Wolf Beecken and Wilko Kunert. It is the world’s first holistic digital therapy for erectile dysfunction. T he Regimen app goes beyond medication to address the root causes of ED with treatments ranging from pelvic floor training, cardiovascular training, diet, mindfulness, education, and more. Recently, the app was CE-certified as a medical device in Europe.
The post World’s first digital therapy for treating erectile dysfunction has launched and raised $2.25M appeared first on UKTN (UK Tech News).